Strategies for immunotherapy of cancer

被引：141

作者：

Melief, CJM ^{[1
]}

Toes, REM ^{[1
]}

Medema, JP ^{[1
]}

Van der Burg, SH ^{[1
]}

Ossendorp, F ^{[1
]}

Offringa, R ^{[1
]}

机构：

[1] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2300 RC Leiden, Netherlands

来源：

ADVANCES IN IMMUNOLOGY, VOL 75 | 2000年 / 75卷

关键词：

D O I：

10.1016/S0065-2776(00)75006-1

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：235 / 282

页数：48

共 300 条

[21] Induction of a CD8(+) cytotoxic T lymphocyte response by cross-priming requires cognate CD4(+) T cell help [J].

Bennett, SRM ;

Carbone, FR ;

Karamalis, F ;

Miller, JFAP ;

Heath, WR .

JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (01) :65-70

[22] ANTIGEN PRESENTATION TO CYTOTOXIC T-LYMPHOCYTES IN-VIVO [J].

BEVAN, MJ .

JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (03) :639-641

[23] CD28 COSTIMULATION CAN PROMOTE T-CELL SURVIVAL BY ENHANCING THE EXPRESSION OF BCL-X(L) [J].

BOISE, LH ;

MINN, AJ ;

NOEL, PJ ;

JUNE, CH ;

ACCAVITTI, MA ;

LINDSTEN, T ;

THOMPSON, CB .

IMMUNITY, 1995, 3 (01) :87-98

[24] Initiation of signal transduction through the T cell receptor requires the peptide multivalent engagement of MHC ligands [J].

Boniface, JJ ;

Rabinowitz, JD ;

Wülfing, C ;

Hampl, J ;

Reich, Z ;

Altman, JD ;

Kantor, RM ;

Beeson, C ;

McConnell, HM ;

Davis, MM .

IMMUNITY, 1998, 9 (04) :459-466

[25]

BOON T, 1994, ANNU REV IMMUNOL, V12, P337, DOI 10.1146/annurev.iy.12.040194.002005

[26] Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies [J].

Brossart, P ;

Heinrich, KS ;

Stuhler, G ;

Behnke, L ;

Reichardt, VL ;

Stevanovic, S ;

Muhm, A ;

Rammensee, HG ;

Kanz, L ;

Brugger, W .

BLOOD, 1999, 93 (12) :4309-4317

[27]

Brossart P, 1998, CANCER RES, V58, P732

[28] High frequency of altered HLA class I phenotypes in invasive colorectal carcinomas [J].

Cabrera, T ;

Collado, A ;

Fernandez, MA ;

Ferron, A ;

Sancho, J ;

Ruiz-Cabello, F ;

Garrido, F .

TISSUE ANTIGENS, 1998, 52 (02) :114-123

[29]

CAMPBELL MJ, 1990, J IMMUNOL, V145, P1029

[30]

CAMPBELL MJ, 1987, J IMMUNOL, V139, P2825

← 1 2 3 4 5 6 7 8 9 10 →